Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis

BACKGROUND & OBJECTIVES: Advanced epithelial ovarian cancer (EOC) is associated with dismal outcome and progression-free survival (PFS) shortens with each subsequent relapse. For patients with recurrent and platinum refractory disease, therapeutic options are limited. Oral metronomic therapy (OM...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Aparna, Malik, Prabhat Singh, Khurana, Sachin, Kumar, Sunesh, Bhatla, Neerja, Ray, M.D., Kumar, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038810/
https://www.ncbi.nlm.nih.gov/pubmed/32048620
http://dx.doi.org/10.4103/ijmr.IJMR_2030_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038810/
https://www.ncbi.nlm.nih.gov/pubmed/32048620
http://dx.doi.org/10.4103/ijmr.IJMR_2030_18

Ejemplares similares